Evidence Summary There is limited long-term B12 monitoring data in GLP-1 trials
With professional oversight, patients can receive guidance on proper use, realistic expectations, progress tracking, and any potential concerns along the way
However, a healthcare provider can offer valuable advice on proper injection techniques, suggest alternative injection sites, or provide recommendations for soothing the skin, if necessary
Consult with a healthcare provider before beginning any new supplement regimen, especially if you have existing health conditions or are taking other medications
In fact, recent semaglutide trials found 3940% of weight lost on the GLP-1 drugs was lean muscle mass
Just the math, the clinical data, and the practical steps you need to stay safe